Dr. Lum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1111 Ne 99th Ave
Suite 301
Portland, OR 97220Phone+1 503-963-2707Fax+1 503-963-2802
Education & Training
University of California (San Francisco)Fellowship, Gastroenterology, 1992 - 1995
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1988 - 1992
University of California, Davis, School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1992 - 2026
WA State Medical License 2019 - 2026
ID State Medical License 2023 - 2025
MT State Medical License 2023 - 2025
OR State Medical License 1989 - 2025
WY State Medical License 2023 - 2025
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACG) American College of Gastroenterology
Publications & Presentations
PubMed
- Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease.Yoo Jin Lee, Dalin Li, Angela Mujukian, Philip Debbas, Melissa Hampton
Inflammatory Bowel Diseases. 2024-08-01 - 18 citationsQuality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease.Gil Y. Melmed, Brant J Oliver, Jason K. Hou, Donald Lum, Siddharth Singh
The American Journal of Gastroenterology. 2021-11-19 - 8 citationsHealth Economic Impact of a Multicenter Quality-of-Care Initiative for Reducing Unplanned Healthcare Utilization Among Patients With Inflammatory Bowel Disease.Christopher V. Almario, Lawrence Kogan, Welmoed K. van Deen, Frank I. Scott, Siddharth Singh
The American Journal of Gastroenterology. 2021-11-03
Press Mentions
Prometheus Laboratories Announces the Launch of PredictrPK™ IFX, a Revolutionary Test Enabling Precision-Guided Dosing for Inflammatory Bowel DiseaseFebruary 17th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
